The Impact of Social Proximity on Conversion to Generic Prescription Medications
研究概览
地位
详细说明
At companies where employees are predominantly union members, we will compare the efficacy of a peer information intervention using a testimonial from a union identified employee to an intervention using a testimonial with no union identification, as well as to a no-testimonial intervention.
The control arm will receive a letter signed by our partner company's Chief Medical Officer, explaining the health and monetary benefits of switching from brand name prescription medication to generic prescription medication. The testimonial treatment arm will receive the exact same letter, but the letter will feature an employee's testimonial along with the first name, last initial, city and state of the employee giving the testimonial. The testimonial and union arm will receive the same letter as the testimonial treatment arm but with the addition of the union affiliation of the employee giving the testimonial.
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Missouri
-
St. Louis、Missouri、美国、63121
- Express Scripts
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Employee of a company that uses Express Scripts as its pharmacy benefits manager.
- Employee at a company with predominantly union employees.
- Currently taking a brand name medication with an exact generic equivalent.
Exclusion Criteria:
- Employees on any psychological prescription medication.
学习计划
研究是如何设计的?
设计细节
- 主要用途:卫生服务研究
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
---|---|
实验性的:Testimonial and Union Arm
The testimonial and union arm will receive the same letter as the testimonial treatment arm but with the addition of the union affiliation of the employee giving the testimonial.
|
At companies where employees are predominantly union members, we will compare the efficacy of a peer information intervention using a testimonial from a union identified employee to an intervention using a testimonial with no union identification, as well as to a no-testimonial intervention.
|
实验性的:Control
The control arm will receive a letter signed by our partner company's Chief Medical Officer, explaining the health and monetary benefits of switching from brand name prescription medication to generic prescription medication.
|
At companies where employees are predominantly union members, we will compare the efficacy of a peer information intervention using a testimonial from a union identified employee to an intervention using a testimonial with no union identification, as well as to a no-testimonial intervention.
|
实验性的:Testimonial Treatment Arm
The testimonial treatment arm will receive the exact same letter as the control arm, but the letter will feature an employee's testimonial along with the first name, last initial, city and state of the employee giving the testimonial.
|
At companies where employees are predominantly union members, we will compare the efficacy of a peer information intervention using a testimonial from a union identified employee to an intervention using a testimonial with no union identification, as well as to a no-testimonial intervention.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Conversion from Brand Name to Generic Prescription Medication
大体时间:One month to one year after the intervention.
|
We will measure conversion rates of employees from brand name to generic prescription medication by treatment arm.
|
One month to one year after the intervention.
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Union Status and Conversation to Generic Medication
大体时间:One month to one year after the intervention.
|
We will see how union affiliation affects the employee conversion rates from brand name to prescription medication by treatment arm.
|
One month to one year after the intervention.
|
合作者和调查者
调查人员
- 首席研究员:David Laibson, Ph.D、National Bureau of Economic Research
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (估计)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- 0002
- P30AG034532 (美国 NIH 拨款/合同)
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.